Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of EUR 133.06 billion. The enterprise value is 179.06 billion.

Market Cap	133.06B
Enterprise Value	179.06B

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Jan 23, 2026

Share Statistics

Current Share Class	5.69B
Shares Outstanding	n/a
Shares Change (YoY)	+0.23%
Shares Change (QoQ)	-0.49%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	66.58%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 20.10 and the forward PE ratio is 9.29.

PE Ratio	20.10
Forward PE	9.29
PS Ratio	2.50
PB Ratio	1.80
P/TBV Ratio	n/a
P/FCF Ratio	17.22
P/OCF Ratio	13.35
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.94, with an EV/FCF ratio of 23.17.

EV / Earnings	27.05
EV / Sales	3.38
EV / EBITDA	7.94
EV / EBIT	11.04
EV / FCF	23.17

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.78.

Current Ratio	1.16
Quick Ratio	0.80
Debt / Equity	0.78
Debt / EBITDA	2.54
Debt / FCF	7.45
Interest Coverage	7.17

Financial Efficiency

Return on equity (ROE) is 8.89% and return on invested capital (ROIC) is 13.68%.

Return on Equity (ROE)	8.89%
Return on Assets (ROA)	5.68%
Return on Invested Capital (ROIC)	13.68%
Return on Capital Employed (ROCE)	11.20%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	658,007
Profits Per Employee	81,711
Employee Count	81,000
Asset Turnover	0.30
Inventory Turnover	1.41

Taxes

Income Tax	-226.55M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.98% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-7.98%
50-Day Moving Average	22.24
200-Day Moving Average	21.51
Relative Strength Index (RSI)	57.07
Average Volume (20 Days)	10,284

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.05

Income Statement

In the last 12 months, Pfizer had revenue of EUR 53.30 billion and earned 6.62 billion in profits. Earnings per share was 1.16.

Revenue	53.30B
Gross Profit	40.40B
Operating Income	16.32B
Pretax Income	6.41B
Net Income	6.62B
EBITDA	21.90B
EBIT	16.32B
Earnings Per Share (EPS)	1.16

Full Income Statement

Balance Sheet

The company has 11.58 billion in cash and 57.61 billion in debt, giving a net cash position of -46.04 billion.

Cash & Cash Equivalents	11.58B
Total Debt	57.61B
Net Cash	-46.04B
Net Cash Per Share	n/a
Equity (Book Value)	73.91B
Book Value Per Share	12.95
Working Capital	5.04B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.97 billion and capital expenditures -2.24 billion, giving a free cash flow of 7.73 billion.

Operating Cash Flow	9.97B
Capital Expenditures	-2.24B
Free Cash Flow	7.73B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.81%, with operating and profit margins of 30.62% and 12.42%.

Gross Margin	75.81%
Operating Margin	30.62%
Pretax Margin	12.02%
Profit Margin	12.42%
EBITDA Margin	41.10%
EBIT Margin	30.62%
FCF Margin	14.50%

Dividends & Yields

This stock pays an annual dividend of 1.49, which amounts to a dividend yield of 6.41%.

Dividend Per Share	1.49
Dividend Yield	6.41%
Dividend Growth (YoY)	-5.99%
Years of Dividend Growth	n/a
Payout Ratio	127.83%
Buyback Yield	-0.23%
Shareholder Yield	6.18%
Earnings Yield	4.97%
FCF Yield	5.81%

Dividend Details

Stock Splits

The last stock split was on July 1, 1999. It was a forward split with a ratio of 3.

Last Split Date	Jul 1, 1999
Split Type	Forward
Split Ratio	3

Scores

Pfizer has an Altman Z-Score of 2.11 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.11
Piotroski F-Score	6